Article
Author(s):
Toronto - A group of Canadian physicians who use Artecoll, an injectable currently awaiting FDA approval, is calling for the development of formal clinical guidelines and further research to help avoid adverse patient reactions.
Dispelling Skin Myths: A New Era of Preventative Care for Anti-Aging, Cleansing, and Sunscreen
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
InflaRx Advances INF904 for CSU and HS with Phase 2a Study
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Interview Intersection: Expert Interviews From December 2024
Photodynamic Therapy is an Effective, Long-Term Treatment for Actinic Keratosis